Articles by tag: cancer-vaccine

FDA Fast Track for dendritic cell therapy dubodencel in melanoma

FDA granted Fast Track status to dubodencel (DOC1021) therapy for the treatment of unresectable melanoma. Learn how personalized dendritic cell vaccine is changing oncoimmunology.

Russian mRNA cancer vaccine included in 2026 state guarantee program

Gamaleya and FMBA cancer vaccines will become free under compulsory health insurance. CAR-T for 7 million rubles and personalized course for 5.8 million. Find out who is eligible for Oncopept and how many applications have already been approved.